SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-102863
Filing Date
2024-04-19
Accepted
2024-04-19 16:05:02
Documents
5
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d735513ddef14a.htm DEF 14A 395301
2 GRAPHIC g735513g01g01.jpg GRAPHIC 293941
3 GRAPHIC g735513g02g02.jpg GRAPHIC 115246
4 GRAPHIC g735513g03k01.jpg GRAPHIC 29530
5 GRAPHIC g735513g34p02.jpg GRAPHIC 60341
  Complete submission text file 0001193125-24-102863.txt   1073956
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38978 | Film No.: 24857732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)